PubRank

G Palù

Author PubWeight™ 72.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J Virol 1995 1.71
2 Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res 2000 1.71
3 Circulating endothelial progenitor cells in subjects with erectile dysfunction. Int J Impot Res 2005 1.65
4 A potential role for the vanilloid receptor TRPV1 in the therapeutic effect of curcumin in dinitrobenzene sulphonic acid-induced colitis in mice. Neurogastroenterol Motil 2007 1.56
5 Human cytomegalovirus and restenosis of the internal carotid artery. Stroke 1996 1.43
6 Early and rapid diagnosis of CMV infection by nonradioactive in situ hybridization in pediatric kidney transplant recipients. Nephron 1992 1.39
7 Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity. J Med Chem 1996 1.29
8 West Nile virus transmission with human cases in Italy, August - September 2009. Euro Surveill 2009 1.18
9 Separation methods for acyclovir and related antiviral compounds. J Chromatogr B Biomed Sci Appl 2001 1.04
10 Role of multivesicular bodies and their components in the egress of enveloped RNA viruses. Rev Med Virol 2009 1.04
11 Genome sequence analysis of the first human West Nile virus isolated in Italy in 2009. Euro Surveill 2009 1.03
12 Intranuclear delivery of an antiviral peptide mediated by the B subunit of Escherichia coli heat-labile enterotoxin. Proc Natl Acad Sci U S A 1999 1.03
13 Synthesis and biological evaluation of N6-cycloalkyl derivatives of 1-deazaadenine nucleosides: a new class of anti-human immunodeficiency virus agents. J Med Chem 1995 0.97
14 On the mechanism of action of quinolone drugs. Trends Microbiol 1993 0.96
15 Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region. Gut 2006 0.96
16 A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2007 0.95
17 HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects. J Clin Microbiol 2011 0.94
18 Clinical and virological findings in the ongoing outbreak of West Nile virus Livenza strain in northern Italy, July to September 2012. Euro Surveill 2012 0.94
19 HSV-2 specific seroprevalence among various populations in Rome, Italy. The Italian Herpes Management Forum. Sex Transm Infect 2000 0.93
20 Effects of CD4 synthetic peptides on HIV type I envelope glycoprotein function. J Immunol 1992 0.92
21 Viral load in HCV RNA-positive pregnant women. Am J Gastroenterol 2001 0.92
22 Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification. J Neuroimmune Pharmacol 2012 0.91
23 Herpes simplex virus chronically infected human T lymphocytes are susceptible to HIV-1 superinfection and support HIV-1 pseudotyping. J Acquir Immune Defic Syndr 1999 0.91
24 T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120. Gene Ther 2005 0.90
25 Engineered E. coli delivers therapeutic genes to the colonic mucosa. Gene Ther 2005 0.90
26 Rapid diagnosis of influenza type A infection: comparison of shell-vial culture, directigen flu-A and enzyme-linked immunosorbent assay. New Microbiol 1996 0.90
27 Clustering and risk factors of methicillin-resistant Staphylococcus aureus carriage in two Italian long-term care facilities. Infection 2008 0.88
28 Measles in Italy, July 2009 to September 2010. Euro Surveill 2011 0.88
29 Inhibitors of HIV-1 Tat-mediated transactivation. Curr Med Chem 2006 0.87
30 Antiviral activity of gyrase inhibitors norfloxacin, coumermycin A1 and nalidixic acid. Biochem Pharmacol 1988 0.87
31 The catalytic subunit of herpes simplex virus type 1 DNA polymerase contains a nuclear localization signal in the UL42-binding region. Virology 2000 0.87
32 Simultaneous polymerase chain reaction detection and restriction typing for the diagnosis of human genital papillomavirus infection. J Virol Methods 1995 0.87
33 Outbreak of serogroup C meningococcal disease in Veneto region, Italy. Euro Surveill 2008 0.86
34 Accurate human papillomavirus genotyping by 454 pyrosequencing. Clin Microbiol Infect 2013 0.86
35 Specific inhibition of herpes virus replication by receptor-mediated entry of an antiviral peptide linked to Escherichia coli enterotoxin B subunit. Proc Natl Acad Sci U S A 1994 0.86
36 Assessment of the lightcycler PCR assay for diagnosis of invasive aspergillosis in paediatric patients with onco-haematological diseases. Mycoses 2008 0.86
37 Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors. Eur J Endocrinol 2001 0.86
38 Strategies for inhibiting function of HIV-1 accessory proteins: a necessary route to AIDS therapy? Curr Med Chem 2009 0.86
39 Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas. Cancer Gene Ther 2006 0.86
40 Oncolysis of pancreatic tumour cells by a gamma34.5-deleted HSV-1 does not rely upon Ras-activation, but on the PI 3-kinase pathway. Gene Ther 2006 0.85
41 West Nile virus: the Italian national transplant network reaction to an alert in the north-eastern region, Italy 2011. Euro Surveill 2011 0.84
42 Use of Vibrio spp. for expression of Escherichia coli enterotoxin B subunit fusion proteins: purification and characterization of a chimera containing a C-terminal fragment of DNA polymerase from herpes simplex virus type 1. Protein Expr Purif 1996 0.84
43 Novel West Nile virus lineage 1a full genome sequences from human cases of infection in north-eastern Italy, 2011. Clin Microbiol Infect 2012 0.84
44 Humoral and cellular immune response to influenza virus vaccination in aged humans. Aging (Milano) 1993 0.84
45 Typing of hepatitis C virus by a new method based on restriction fragment length polymorphism. Intervirology 1999 0.84
46 Disruption of the interactions between the subunits of herpesvirus DNA polymerases as a novel antiviral strategy. Clin Microbiol Infect 2005 0.83
47 PDE-5 inhibitor, Vardenafil, increases circulating progenitor cells in humans. Int J Impot Res 2005 0.83
48 Increased expression of LGI1 gene triggers growth inhibition and apoptosis of neuroblastoma cells. J Cell Physiol 2006 0.83
49 New perspectives for gene therapy in endocrinology. Eur J Endocrinol 2000 0.82
50 Expression of the endothelin-converting enzyme gene in human tissues. Biochem Biophys Res Commun 1995 0.81
51 Gene expression, localization, and characterization of endothelin A and B receptors in the human adrenal cortex. J Clin Invest 1994 0.81
52 Detection of polyomaviruses and herpesviruses in human adrenal tumors. Oncogene 2007 0.80
53 Enteroviral genome in native hearts may influence outcome of patients who undergo cardiac transplantation. Diagn Mol Pathol 1999 0.79
54 HIV-1-mediated delivery of a short hairpin RNA targeting vascular endothelial growth factor in human retinal pigment epithelium cells. Br J Ophthalmol 2009 0.79
55 Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group. Infection 2013 0.79
56 Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer. Gene Ther 1998 0.79
57 Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation. J Clin Virol 2005 0.79
58 Quantitative analysis of ribonucleotide triphosphates in cell extracts by high-performance liquid chromatography and micellar electrokinetic capillary chromatography: a comparative study. Anal Chem 1994 0.78
59 Shift from Conn's syndrome to Cushing's syndrome in a recurrent adrenocortical carcinoma. Eur J Endocrinol 2005 0.78
60 Functional Interaction Between the ESCRT-I Component TSG101 and the HSV-1 Tegument Ubiquitin Specific Protease. J Cell Physiol 2015 0.78
61 Molecular epidemiology of Enterococcus faecium isolates from an Italian hospital. Infection 2011 0.78
62 Switching of inferred tropism caused by HIV during interruption of antiretroviral therapy. J Clin Microbiol 2010 0.78
63 Anti-HIV genetic treatment of antigen-specific human CD4 lymphocytes for adoptive immunotherapy of opportunistic infections in AIDS. Gene Ther 1997 0.78
64 Antiviral properties of psoralen derivatives: a biological and physico-chemical investigation. Biochem Pharmacol 1984 0.77
65 Cytomegalovirus and BK-Virus co-infection of a clinically non-functioning adrenal adenoma: innocent bystanders or new pathogenetic agents? Eur J Histochem 2006 0.77
66 Control of the expression of an early gene of SV40 with natural and modified oligonucleotides. Nucleic Acids Symp Ser 1991 0.77
67 Antibacterial activity of cefditoren against major community-acquired respiratory pathogens recently isolated in Italy. J Chemother 2008 0.77
68 Brain resistance to HSV-1 encephalitis in a mouse model. J Neurovirol 2002 0.77
69 Investigation of BRAF and CTNNB1 activating mutations in adrenocortical tumors. J Endocrinol Invest 2009 0.77
70 Water-soluble polysaccharide-anthracycline conjugates: biological activity. Anticancer Drug Des 1992 0.77
71 Interaction between second generation anthracyclines and DNA in the nucleosomal structure. Nucleic Acids Res 1991 0.77
72 In vitro basis for schedule-dependent interaction between gemcitabine and topoisomerase-targeted drugs in the treatment of colorectal cancer. Ann Oncol 2006 0.77
73 Aspartic protease inhibitors. An integrated approach for the design andsynthesis of diaminodiol-based peptidomimetics. Eur J Biochem 2000 0.76
74 DNA-binding of water-soluble furocoumarins: a thermodynamic and conformational approach to understanding different biological effects. Nucleic Acids Res 1984 0.76
75 Gene stereotactic neurosurgery for recurrent malignant gliomas. Stereotact Funct Neurosurg 1997 0.76
76 Autocrine-paracrine role of endothelin-1 in the regulation of aldosterone synthase expression and intracellular Ca2+ in human adrenocortical carcinoma NCI-H295 cells. Endocrinology 1997 0.76
77 Crystal structure of the B subunit of Escherichia coli heat-labile enterotoxin carrying peptides with anti-herpes simplex virus type 1 activity. J Biol Chem 1999 0.76
78 Efficient extracellular production of hybrid E. coli heat-labile enterotoxin B subunits in a marine Vibrio. FEMS Microbiol Lett 1994 0.76
79 Acyclovir resistance/susceptibility in herpes simplex virus type 2 sequential isolates from an AIDS patient. J Acquir Immune Defic Syndr 1991 0.76
80 PCR in meningoencephalitis diagnosis. Scand J Infect Dis 2000 0.75
81 Endothelin-1 and its receptors A and B in human aldosterone-producing adenomas. Hypertension 1995 0.75
82 Effect of differential growth conditions on the dTTP pool size in herpes simplex virus-infected Vero cells. Biochem Soc Trans 1995 0.75
83 Screening of HBV-DNA in chronic HBsAg carriers. Microbiologica 1991 0.75
84 [The effect of 12-O-tetradecanoylphorbol-13-acetate on acute myeloid leukemia cells obtained directly from the patient. Failure of the compound to induce a "true" maturation]. Acta Biomed Ateneo Parmense 1981 0.75
85 [Gene therapy in cardiovascular medicine: reality or fantasy?]. Ann Ital Med Int 1996 0.75
86 Disruption of herpes simplex virus ribonucleotide reductase quaternary structure by peptide inhibitors as a novel approach to antiviral therapy. J Chemother 1995 0.75
87 A search for potential antitumor agents: biological effects and DNA binding of a series of anthraquinone derivatives. Mol Pharmacol 1986 0.75
88 Quantitative analysis of ribonucleoside triphosphates in human lymphoid cells by micellar electrokinetic capillary chromatography. Ann Clin Biochem 1999 0.75
89 [Structure-activity relationship of several mitoxantrone analogues]. G Ital Chemioter 1995 0.75
90 Detection of the effects of intercalating and non-intercalating drugs on DNA structure. Biochem Pharmacol 1988 0.75
91 Tamoxifen in disseminated breast cancer. Tumori 1978 0.75
92 E. coli heat-labile enterotoxin B subunit as a carrier for delivery of a peptide with anti-HSV activity. Biochem Soc Trans 1992 0.75
93 [Antiviral activity of furocoumarins]. G Ital Chemioter 1984 0.75
94 Changes in HCV viremia following LDL apheresis in a HCV positive patient with familial hypercholesterolemia. Int J Artif Organs 1999 0.75
95 Nucleoside uptake in macrophages from various murine strains: a short-time and a two-step stimulation model. Biochem Biophys Res Commun 1991 0.75
96 Some theoretical aspects of the mechanism of action of benzhydrazone, an inhibitor of glycosylation in herpes simplex virus. Microbiologica 1989 0.75
97 Amido analogs of mitoxantrone: physico-chemical properties, molecular modeling, cellular effects and antineoplastic potential. Anticancer Drug Des 1997 0.75
98 Immunotherapy. Oral route to Holy Grail? Gene Ther 2003 0.75
99 A dysfunctional factor X (factor X San Giovanni Rotondo) present at homozygous and double heterozygous level: identification of a novel microdeletion (delC556) and missense mutation (Lys(408)-->Asn) in the factor X gene. A study of an Italian family. Thromb Res 2001 0.75
100 On the complex nature of the antiviral activity of coumermycin A1: its interference with the replication of herpes simplex virus type 1. Antiviral Res 1986 0.75
101 A model for the sequence-dependent DNA binding of 4',6-diamidino-2-phenylindole (DAPI). Biochem Biophys Res Commun 1995 0.75
102 Antitumor activity of new anthraquinone derivatives. Chemioterapia 1986 0.75
103 [Pregnancy in women infected with the hepatitis C virus]. Acta Biomed Ateneo Parmense 2000 0.75
104 Interaction of nucleosomes with anthracycline antibiotics: relevance to anticancer activity. Biochem Pharmacol 1988 0.75
105 Influence of yeasts and of their constituents on nucleoside uptake in peritoneal murine macrophages. FEMS Microbiol Lett 1991 0.75
106 Fine mapping of the human endothelin-converting enzyme gene by fluorescent in situ hybridization and radiation hybrids. Biochem Biophys Res Commun 1996 0.75
107 Ten years of BSE surveillance in Italy: neuropathological findings in clinically suspected cases. Res Vet Sci 2011 0.75
108 Coumermycin inhibition of murine retrovirus replication in cultured cells. J Antimicrob Chemother 1984 0.75
109 Topoisomerase I, II alpha and II beta mRNA expression in peripheral blood mononuclear cells of patients with solid tumor: preliminary results. Ann Oncol 2006 0.75
110 Bis-substituted hydroxy-anthracenediones: DNA binding and biological activity. Anticancer Drug Des 1987 0.75
111 3'-5' L-capped-antisense oligodeoxynucleotides targeted at the SV40 T-antigen gene: pharmacological and biological properties. New Microbiol 1996 0.75
112 Nature of toxicity for chick embryo fibroblast cells of coumermycin A1 and its physico-chemical interactions with protein and nucleic acid. Biochem Pharmacol 1984 0.75
113 Expression of colony stimulating activity (CSA) and production of colony forming unit (s) (CFU-c) by acute myeloid leukaemia cells showing maturation in short-term culture. Haematologica 1982 0.75
114 Measurement of human cytomegalovirus-associated DNA polymerase activity in patient urine as a potential diagnostic tool. Intervirology 1996 0.75
115 Combined strategies for gene therapy of AIDS. Gene Ther 1997 0.75
116 Analysis of human immunodeficiency virus type 1 vector cis- and trans-acting elements production by means of Semliki Forest virus. Gene Ther 2008 0.75
117 Selective modification of thymidine by dansyl group and biological effects of the dansyl derivatives. Biochem Pharmacol 1988 0.75
118 Abnormal propeptide processing resulting in the presence of two abnormal species of protein C in plasma: characterization of the dysfunctional protein C Padua3 (protein C(R-1L/propeptide)). Thromb Haemost 2001 0.75
119 Production of epidermal growth factor in human prostatic cells cultured in vitro. Ann Anat 2000 0.75
120 Analysis of the antigen specific T cell repertoires in HIV infection. Immunol Lett 2001 0.75
121 Diagnosis of HIV infection from bloodstains by PCR. A further marker for identification. Int J Legal Med 1995 0.75
122 Synthesis and biological activity of dansyl thymidines. Farmaco 1989 0.75